Laser Treatment for Subfoveal Neovascular Membranes in Ocular Histoplasmosis Syndrome: Results of a Pilot Randomized Clinical Trial

Choroidal neovascularization secondary to tuberculosis: Presentation and management

“…Several therapeutic strategies have been attempted for uveitis-related CNV: focal laser photocoagulation, 6 photodynamic therapy with verteporfin, 7 local and systemic corticosteroids, 8 systemic immunosuppression, 9 surgery, 10 and most recently, intravitreal bevacizumab injections. 11 , 12 Given the elevated VEGF levels associated with intraocular TB infections, anti-VEGF therapy may effectively suppress TB-related CNV.…”

Choroidal neovascularization secondary to tuberculosis: Presentation and management

“…Several therapeutic strategies have been attempted for uveitis-related CNV: focal laser photocoagulation, 6 photodynamic therapy with verteporfin, 7 local and systemic corticosteroids, 8 systemic immunosuppression, 9 surgery, 10 and most recently, intravitreal bevacizumab injections. 11 , 12 Given the elevated VEGF levels associated with intraocular TB infections, anti-VEGF therapy may effectively suppress TB-related CNV.…”

Choroidal neovascularization secondary to tuberculosis: Presentation and management

“…Several therapeutic strategies have been attempted for uveitis-related CNV: focal laser photocoagulation, 6 photodynamic therapy with verteporfin, 7 local and systemic corticosteroids, 8 systemic immunosuppression, 9 surgery, 10 and most recently, intravitreal bevacizumab injections. 11 , 12 Given the elevated VEGF levels associated with intraocular TB infections, anti-VEGF therapy may effectively suppress TB-related CNV.…”

Choroidal neovascularization secondary to tuberculosis: Presentation and management

“…Several therapeutic strategies have been attempted for uveitis-related CNV: focal laser photocoagulation, 6 photodynamic therapy with verteporfin, 7 local and systemic corticosteroids, 8 systemic immunosuppression, 9 surgery, 10 and most recently, intravitreal bevacizumab injections. 11 , 12 Given the elevated VEGF levels associated with intraocular TB infections, anti-VEGF therapy may effectively suppress TB-related CNV.…”